RxDoctor Payments Data

Elizabeth King, MD

Vascular Surgery · Boston, MANPI 1740500107

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 46.7% of the total. That places this record below the midpoint for vascular surgery clinicians in MA, where the typical reported total is $4,155.

$4,846in general payments, 2019–2025

Across 42 payments — averaging $115.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Silk Road Medical, Inc.$1K
  • BD$750
  • Cook Medical LLC$479
  • Humacyte Global, Inc.$138
  • Bolton Medical Inc$138
  • plus $40 from 2 others
$55,021in research payments, 2019–2025

Across 11 payments — averaging $5001.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$36K
  • Novo Nordisk AS$19K

What the payments were for

  • Speaking & faculty fees$75015%
  • Travel & lodging$1,80237%
  • Food & beverage$2,29447%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,846 in reported general payments places this provider in the 50th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$47,886
Medicare patients
249
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →